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ABSTRACT Ferritin is an iron storage protein expressed in varying concentrations in mammalian cells. The deposition of ferric
iron in the core of ferritin makes it amagnetic resonance imaging contrast agent, and ferritin has recently been proposed as a gene
expression reporter protein for magnetic resonance imaging. To date, ferritin has been overexpressed in vivo and has been
coexpressed with transferrin receptor to increase iron loading in cells. However, ferritin has a relatively low T2 relaxivity (R2 
1 mM1s1) at typical magnetic ﬁeld strengths and so requires high levels of expression to be detected. One way to modulate the
transverse relaxivity of a superparamagnetic agent is to cause it to aggregate, thereby manipulating the magnetic ﬁeld gradients
throughwhichwater diffuses. In thiswork, it is demonstrated by computer simulation and in vitro that aggregation of ferritin can alter
relaxivity. The effects of aggregate size and intraaggregate perturber spacing onR2 are studied. Computermodeling indicates that
theoptimal spacing of the ferritinmolecules in aggregate for increasingR2 is 100–200nm for a typical rangeofwater diffusion rates.
Chemical cross-linking of ferritin at 12 A˚ spacing led to a 70% increase in R2 compared to uncross-linked ferritin controls. To
modulate ferritin aggregation in a potentially biologically relevant manner, ferritin was attached to actin and polymerized in vitro.
The polymerization of ferritin-F-actin caused a 20% increase in R2 compared to unpolymerized ferritin-G-actin. TheR2-value was
increased by another 10% by spacing the ferritin farther apart on the actin ﬁlaments. The modulation of ferritin aggregation by
binding to cytoskeletal elements may be a useful strategy to make a functional reporter gene for magnetic resonance imaging.
INTRODUCTION
Magnetic resonance imaging (MRI) has emerged as an im-
portant technology for the noninvasive assessment of bio-
logical tissue and has enabled the assessment of anatomical
and physiological processes for research and clinical appli-
cations. Some advantages of MRI as an imaging modality are
its lack of ionizing radiation, high spatial resolution, and
flexibility in type of contrast mechanisms. MRI offers the
advantage of whole-tissue penetration with high-resolution
(hundreds of microns in each dimension) in a reasonable
period of time. MRI also has been used to obtain information
about molecular events in vivo (1–6).
There has been some interest in developing reporter protein
strategies to use MRI to image gene expression. The large
impact of green fluorescent protein and luciferase for optical
imaging of gene expressionmakes it attractive to have anMRI
reporter protein that would enable high-resolution imaging
throughout an organ. A reporter gene is a DNA construct that
enables cells to express a protein that changes theMRI signal.
The expression of the protein can be linked to activity of a
different promoter (7). There have been a number of dem-
onstrations of magnetic resonance (MR) reporter proteins
including creatine kinase and arginine kinase, transferrin
receptor, and polyarginine peptides (7). None of these strat-
egies has found widespread use. Recently, ferritin has been
proposed as an MRI reporter protein. The presence and
overexpression of ferritin, an iron storage protein, has been
detected in vitro and in vivo using MRI (8–11). However,
wild-type ferritin is a poor MR contrast agent, with per-iron
relaxivity ;10- to 100-fold lower than similarly sized syn-
thetic iron oxide particles used for cell labeling (12). Wild-
type ferritin also has a lowper-ferritin relaxivity due to the fact
that ferritin usually fills to approximately one third to one half
of its maximum iron capacity (13). Nonetheless, there are
some characteristics of ferritin that potentially could be im-
proved.
Ferritin has a magnetic moment that interacts with a strong
magnetic field to produce a perturbation that is detectable with
MRI (14–18). The electron spins of the ferritin iron atoms are
antiferromagnetically coupled, but the relatively small size of
the core creates a cooperativity of spins and results in a su-
perparamagnetic molecule. In an MRI of samples containing
suspensions of ferritin, transverse relaxation rates are in-
creased with an increase in ferritin concentration. The longi-
tudinal (R1) and transverse (R2) relaxivities of different ferritin
types depend on the amount of Fe31 in the core, field strength,
and temperature (17). A goal of previous works has been to
noninvasively quantify the amount of iron present in the liver,
spleen, and other organs based on ferritin relaxivity (19,20).
These measurements are useful for studying tissue damage
due to iron storage diseases. The relaxivity of ferritin is on the
order of 1–10 mM1s1 at typical magnetic field strengths in
the range of 1–10 T. Although synthetic versions of ‘‘mag-
netoferritin’’ have been produced in vitro (21,22), it is not yet
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clear that the fundamental relaxivity of the native ferritin
molecule can be increased in vivo.
Studies of the tissue distribution of ferritin have empha-
sized the fact that the spatial organization of ferritin can affect
the apparent R2. One way to modulate the relaxivity of a
superparamagnetic molecule is to allow it to aggregate (23–
26). Indeed, controlling the aggregation has been proposed as
a method for creating functional MRI contrast agents (26–
28). The goal of this work is to determine whether the
relaxivity of ferritin could be manipulated by controlled ag-
gregation and to measure the conditions required to optimize
aggregation to modulate R2. We developed a computational
model of ferritin in aggregation states of varying size and
spacing. The results indicate that ferritin molecules in aggre-
gates are optimally spaced at100 nm for peak R2 relaxivity.
To verify the findings of the model, we chemically cross-
linked ferritin at close distance in vitro to study the change inR2.
Furthermore, we demonstrate a way to achieve spacing on
the order of 100 nm in vitro by allowing ferritin to bind to a
biological structure that polymerizes and depolymerizes at
the correct distance. Actin, which is known to polymerize and
change its structure with changes in the intracellular and
extracellular environment (29–32), represents a large fraction
(5%) of the total cellular-expressed protein and may thus be
an appropriate scaffold to bind to ferritin to create optimal
spacing. Actin is a monomer that hydrolyzes ATP to form
filamentous polymers in vivo. Actin is ubiquitous in mam-
malian cells; it forms the cytoskeletal scaffold with which the
nucleus, membrane, and organelles interact. The actin cyto-
skeleton interacts with cell-surface receptors to allow for
cytokine-mediated cell motility. MRI contrast agents have
been developed to detect cell molecular events occurring on
the timescale of actin polymerization (33). We examined
whether ferritin cross-linked to actin in vitro could be used to
space ferritin at large distances and affect R2. The results
indicate that ferritin relaxivity can be modulated by poly-
merization of actin, which opens up the possibility of creating
a ferritin–actin binding protein fusion that can report on the
functional state of actin in cells.
MATERIALS AND METHODS
Theoretical simulations
A computational model was created (Microsoft Visual C11, version 6.0,
Microsoft, Redmond, WA) to predict the MRI signal amplitude arising from
water in a solution containing either disperse or aggregated perturbers. The
overall scheme of the simulation was similar to that developed by Weisskoff
et al (23) to study the effects of microscopic spherical perturbers on MRI
relaxation. In this work, however, we looked at the effects of submicron
perturber geometries and clustering on the MRI signal. Additionally, we
developed a simulation of a Carr-Purcell Meiboom-Gill MRI pulse sequence,
using a fixed diffusion time.
Spherical dipole perturbers were distributed randomly inside a simulated
voxel volume with 10 mm in each of three dimensions. The perturber con-
centration was 6.1 nM (corresponding to a ferritin subunit concentration of
;145 nM), and the perturbers were not allowed to overlap. Each perturber
was given a surface field offset of 20 G. An 11.7-T magnetic field was as-
sumed. A water molecule, assumed to be infinitely small, was then placed
within a smaller volume (100-nm isotropic) inside the center of the simulated
voxel and allowed to diffuse through the 10mm3 isotropic voxel. To simulate
the effects of perturber aggregation on the MR signal, a single perturber was
placed at a random location, and then a specified number of perturbers were
placed at fixed locations around it to form a cube. The spacing between
individual perturbers was varied, as was the number of perturbers in each of
the clusters, but the total number of perturbers in the simulated volume was
held constant.
To simulate a multiple-echo (Carr-Purcell Meiboom-Gill ) experiment, an
echo-time (TE) was specified, and the water underwent a three-dimensional
random walk through the field of perturbers during TE at a rate of 10,000
steps per second. Before each step, a random angle between each of three
axes was computed to determine the direction of the next step, and water was
not allowed to penetrate the perturbers. The effective diffusion coefficient
based on empirical calculation of the RMS diffusion distance of water over
TE was 4.24 x 104 mm2/s, or  1/5 the diffusion coefficient of free water.
After each step, the magnetic field at the location of the water molecule was
calculated by adding the field contributions from every perturber at the lo-
cation of the water. The phase was reversed five times to simulate five
echoes, and signal intensity was calculated between each echo. We note that
this would simulate an instantaneous 180 pulse, which is impossible in
experiment. The perturbers were redistributed before each water molecule
was placed in the field to randomize the spatial distribution of the perturbers.
The total phase of the water molecule, which was the accumulated sum of the
frequencies during the whole TE, was stored. This process was repeated for a
total of 10,000 water molecules with a varying number of perturbers. The
measurements of signal intensity with these parameters were accurate to
,1%, as long as the normalized signal intensity was .0.1. The measure-
ments were all made in this range.
Chemical cross-linking of ferritin
To establish whether short-distance aggregation of ferritin could increase
per-iron relaxivity in vitro, we created ferritin aggregates that were cross-
linked at short distances. Iron concentrations of all stock ferritin samples used
in this work were obtained from West Coast Analytical Service, Santa Fe
Springs, CA. Cationized horse spleen ferritin (CF), a polycationic derivative
of horse spleen ferritin, was obtained from Sigma (St. Louis, MO). To
construct CF, the carboxyl groups of ferritin were activated by the manu-
facturer with a water-soluble carbodiimide and then reacted with N,N di-
methyl-1,3 propanediamine to introduce free amine groups to the CF (34).
Based on the electrometric titration of CF by Danon et al. (34), CF contains
;80–100 added free amine groups per ferritin cage.
We used 3,39-dithiobis(sulfosuccinimidylpropionate) (DTSSP; Pierce,
Rockford, IL) to cross-linked CF. DTSSP is a soluble succinimidyl ester
containing a disulfide bond that links binding sites to two free amines.
DTSSP forms a 12 A˚ (0.1 nm) spacer between neighboring cross-linked
proteins. The structure of DTSSP is shown in Fig. 1 a, with binding sites for
the ferritin subunits indicated by arrows.
The DTSSP cross-linking reaction was performed in phosphate-buffered
saline (PBS), and 2-amino-2-hydroxymethyl-1,3-propanediol (TRIS) com-
petitively inhibited the reaction. In addition, cross-linking with DTSSP was
reversed using dithiothreitol (DTT), which reduces (cleaves) the disulfide bond
between the DTSSP cross-linkers. Before use, the DTSSP was mixed with
PBS at a 10mg/mLconcentration and put into solution by vigorous vortexing.
The experimental design for the ferritin aggregation experiments is shown
in Fig. 1 b. In cross-linked and control experiments, respectively, CF was
mixed with 0.9 mL PBS or 0.9 mL TRIS buffer (pH 7.4, 1 M) in concen-
trations from 50 nM to 500 nM (CF cage polymers). In both cross-linked and
control samples, the DTSSP-PBS solution was added and thoroughly mixed
by pipetting. After 1 h, 0.9 mL of TRIS was mixed by pipette with the cross-
linked samples, and 0.9 mL of PBS was mixed with the control samples,
making the total volumes (and ferritin, TRIS, and PBS concentrations) of the
cross-linked and control samples the same. Thus, any differences in the MR
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properties between cross-linked and control samples should be due only to
the time allowed for aggregation to occur before the TRIS was added. The
samples were then mixed 1:1 with 2% molten low-melting point agarose
(SEAChem, Madison, GA.), at ;40C, in glass test tubes and allowed to
cool for 1 h at room temperature before imaging. To determine whether re-
versal of cross-linking could reverse any change in R2 with aggregation, we
added 50 mL of 10 mg/mL DTT to 900 mL of the cross-linked samples and
900 ul of the control samples. The experiments were repeated three times
using separate cross-linked samples and control samples. The aggregate size
distribution for the conditions of these experiments was determined by
electron microscopy (described below).
Actin-ferritin conjugation and
actin polymerization
As described in the Results section, the computer simulations predicted a
dependence of ferritin relaxivity on the spacing between individual ferritins
in the aggregate. To explore this effect in vitro and to make a biologically
relevant construct of aggregated ferritin, we attached ferritin to actin and
allowed actin polymerization to determine the spacing of the ferritin mole-
cules.
Biotinylated rabbit skeletal muscle actin and all actin buffer solutions
were purchased from Cytoskeleton, Inc. (Denver, CO). Avidin-ferritin,
composed of horse-spleen ferritin conjugated to avidin (EY Laboratories,
Inc., San Mateo, CA), was used. We added 2 mL of dH2O and 48 mL of
general actin buffer (5 mMTris, 0.2 mMCaCl2, and 0.2 mMATP) to 2mg of
dehydrated biotin-actin and incubated for 1 h at room temperature.
To determine whether actin-ferritin could polymerize, 100 mL of avidin-
ferritin (5 mg/mL) or general actin buffer was added to 20 mL of the biotin-
actin solution, and the samples were incubated 30 min at room temperature.
We added 12mL of polymerization buffer (500 mMKCl, 20 mMMgCl2, and
10 mMATP) 1 h before, or directly before, suspension in 2%molten agarose
in dH2O (Bioline USA Inc., Randolph, MA) for transmission electron mi-
croscopy (TEM), or left it in solution for MRI. The concentration of ferritin
cages was 3.5 mM. Hereafter, globular actin (G-actin) refers to unpoly-
merized actin, and F-actin refers to actin incubated with polymerization
buffer for 1 h.
To modulate R2 by modifying the spacing between each of the ferritin
molecules, we mixed biotin-actin with rhodamine-actin in proportions of
1:1.5 and 1:5, then allowed the avidin-ferritin to conjugate with the mixture
before polymerization (as described above). This should allow only some of
the ferritin to be attached to F-actin thus increasing the overall distance be-
tween the ferritin cages. The samples were observed under electron micros-
copy (see below, with samples prepared by adsorption to the carbon grid).
Fluorescence microscopy
Actin, both ferritin-conjugated and by itself in G- and F-forms, was incubated
with a rhodamine-phalloidin (Cytoskeleton) conjugate for fluorescence mi-
croscopy, which was performed using a Leica MZ FLIII stereo microscope
with a TRITC/DiI filter (excitation 540 nm, emission 605 nm; Chroma
Technology Corp, Rockingham, VT). For imaging, 10 mL of the actin
sample was dropped onto a microscope slide and covered with a cover slip.
Electron microscopy
All images were taken with a Jeol electron microscope (JEM-200CX; Pea-
body, MA). For embedded samples of cross-linked and actin-conjugated
ferritin, these solutions were mixedwith 10% agarose. Cacodylate buffer was
added to the agarose sample in a test tube and stored at 4C. Selected areas
were trimmed, dehydrated with a graded series of ethanol mixtures, in-
filtrated with gradedmixtures of ethanol and epoxy resin (SPI Supplies,West
Chester, PA), and embedded in epoxy resin. Polymerization of the resin was
carried out at 60C for # 48 h. For carbon-grid adsorption, samples were
adsorbed onto 400 hexagonal mesh, thin bar Cu grids (EMS, Fort Wash-
ington, PA) coated with 1% Formvar in ethylene dichloride (EMS) by set-
tling for 5 min, and blotting and drying for 15 min. Separate grid-adsorbed
samples were then negatively stained with 0, 0.25%, and 0.5% uranyl acetate
in water.
Two different preparations of actin-ferritin were prepared for the cross-
linked and control conditions. In the first, cross-linked and control samples
were mixed 1:1 with 10% low-melting point agar and allowed to cool. In one
of the samples, containing no ferritin, 0.5% uranyl acetate in 0.1 M acetate
buffer was added to the section to provide negative contrast and to enable
visualization of the actin filaments. Experiments were repeated three times
with similar results.
Ferritin was easily identified with no negative staining and appeared to be
arranged in filaments. Additionally, F-actin filaments were identified with
uranyl acetate staining, but it was difficult to obtain sufficient contrast to
identify actin and ferritin together due to absorption of uranyl acetate by the agar.
The samples were therefore adsorbed onto carbon grids, as described above.
MRI
Samples of the chemically cross-linked ferritin in agar were imaged in 1.5
mL Eppend (Sigma Aldrich, St. Louis, MO) or 200 mL tubes and placed in a
35 mm ID Bruker transmit/receive probe in a Bruker 11.7T scanner (Bruker
Biospin, Billerica, MA) with a 31-cm bore magnet (Magnex Scientific,
Oxford, England). For T2 mapping, a multishot multiecho pulse sequence
was used (TE/TR ¼ 6/3000 ms). Five slices of 0.5-mm thickness were
acquired with 0.5 mm between each slice. In-plane resolution was 200 3
200 mm using a 128 3 128 matrix with a 25.6-mm2 field of view.
Actin was imaged in solution. We used a custom-built, 55 mm ID
transmit/receiver radiofrequency coil that allowed the samples to remain
upright. All imaging parameters were the same as with the chemically cross-
linked samples.
FIGURE 1 (a) The short (12 A˚; 1 nm) spacer succinimidyl ester DTSSP
was cross-linked on either side to an amine group on cationized horse-spleen
ferritin. The thick arrows at left and right show the location of the ferritin
attachment. The spacer was cleaved by DTT at the location of the thin arrow.
(b) Illustration of experimental protocol for ferritin aggregation with
DTSSP. Volumes of buffers were equal between control and aggregate
samples. Aggregation was controlled by the addition of free amines in the
form of TRIS buffer either before (control) or after (aggregate) cross-linking.
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RESULTS
Simulations
In simulations of the MRI signal intensity using a single-
voxel approach, ferritin-sized perturbers were randomly
distributed in the pixel. The perturbers were allowed to ag-
gregate with 2, 3, 4, or 5 perturbers in each dimension with no
spacing between the perturbers. The space between the edges
of the perturbers was also varied from 50 nm to 500 nm, and
theMRI signal intensity was compared between the perturber
orientations.
Fig. 2 a shows a typical plot of the simulated MRI signal
intensity (on a negative log scale) as a function of TE, at each
echo, for a zero-distance perturber spacing, with the number
of perturbers in the aggregate varied from 8 (2 3 2 3 2
perturbers) to 125 (5 3 5 3 5 perturbers). Relaxivity was
estimated by the slope of each curve. Fig. 2 b shows the re-
sulting change in R2 compared to the case of close-packed,
(0 nm), aggregate of the same number of perturbers. Fig. 2 c
shows the same data compared to the case of randomly dis-
tributed ferritins. The simulation shows that increasing the
distance between ferritins in varying size aggregates can
cause an increase in R2 by #60% compared to an aggregate
with no space between ferritins. In comparison to randomly
distributed ferritins, aggregation can either increase or de-
crease R2 depending on the ferritin spacing. This effect is
assumed to come from the transition of the relaxivity between
static-dephasing and diffusion-limited regimes when ferritin
spacing is modulated (23). The peak relaxivity in this case
occurred with 64 perturbers, corresponding to a perturber
diameter of ;500 nm. The greatest gain in R2 was achieved
when aggregate size was modulated in the range of 50–100
perturbers.
We examined whether the sensitivity to aggregate size was
due to the fact that, when more ferritins are in an aggregate, a
water molecule may not experience the magnetic field of the
cluster during the random walk. We therefore compared the
magnetic field offsets at the locations of several water mol-
ecules during the walk. All water molecules were found to
experience at least 1 magnetic field offset due to the per-
turbers during the random walk (data not shown).
Chemical cross-linking of ferritin
Ferritin aggregates were observed in cross-linked samples
using TEMwith no negative staining. The spatial distribution
of grid-adsorbed normal and aggregated ferritin is shown in
Figs. 3, a and b, respectively. The distance across the large
aggregates was measured to be ;150 nm on average, mea-
sured by the longest axis across embedded aggregates. The
distribution of aggregate sizes for aggregated and native fer-
ritin is shown in Fig. 3 c.
The MRI signal intensity in cross-linked and control sam-
ples decreased with increasing ferritin concentration. Typical
MR images are shown in Fig. 4 a, with increasing concen-
trations of ferritin. The sample of aggregated ferritin was
visibly darkened in T2-weighted images (TE ¼ 36 ms)
compared to controls. R2 values, determined by fitting the
signal decay with a monoexponential function, were used to
FIGURE 2 Simulation of the effects of aggregate size and perturber
spacing onMR signal intensity with a CPMG (multiple-echo) pulse sequence
with 4 ms TE. (a) Signal attenuation is shown to increase with the number of
perturbers in the aggregate. (b) R2 changes are shown for each aggregate size
compared to the case of zero-length aggregation of the same number of
perturbers. Peak relaxation occurred at a spacer distance of 100–150 nm for
every aggregate. (c) The same data are shown compared to the case of
randomly distributed perturbers in the voxel. With larger aggregate sizes, R2
decreases due to shielding of the diffusing water from the central perturbers.
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compute relaxivity (per iron). The computed R2-values are
seen in Fig. 4 b, corresponding to the ferritin concentrations
used in the samples of Fig. 4 a. The values of R2 relaxivity,
obtained by linear regression of the curves of Fig. 4 b, are
shown in Fig. 4 c. Cross-linking of ferritin increased R2 re-
laxivity by 70%, which was statistically significant (p, 0.05,
t-test). The addition of DTT to reduce the disulfide linker
caused relaxivity to decrease to the level of the control.
From these results, we concluded that chemical cross-
linking of ferritin at short distances can increase R2 relaxivity.
This leads to a decrease in MRI signal intensity that is de-
tectable at reasonable ET-values (10–40 ms) at high-field
strengths. Additionally, the effect of cross-linking on R2 re-
laxivity can be reversed by cleavage of the cross-linker.
Actin-ferritin conjugation and
actin polymerization
To increase ferritin spacing to distances approaching 100 nm,
we used polymerized actin as a scaffold for ferritin binding.
The polymerization of actin in vitro was confirmed by fluo-
rescence microscopy using rhodamine-phalloidin. No struc-
tured fluorescence was observed with G-actin samples (Fig.
5 a), whereas filaments of F-actinwere seen (Fig. 5 b). The size
of the filaments was on the order of 10–100 mm in length.
G- and F-actin conjugates of ferritin were visible in TEM
after adsorption to the carbon grid (Fig. 5, c and d), con-
firming that F-actin could still polymerize when ferritin was
attached. F-actin was also visible in TEM of an agarose-
embedded sample. Uranyl acetate staining provided excellent
contrast of unpolymerized ferritin-actin and polymerized
actin filaments in the agar (Fig. 5, e and f). The iron cores of
individual ferritin molecules attached to polymerized actin
were visible in TEMwith no counterstain in agar blocks (Fig.
5 f). In this experiment, the close spacing of the individual
ferritins was expected, because the ferritin concentration was
equal to the actin concentration, and the ferritin molecules
were separated by 5 nm. Filaments were ;200 nm in length
and 5–10 nm in width. No filaments were observed in the
G-actin sample, but there was some aggregation of ferritin-
G-actin in grid-adsorbed samples, as seen in Fig. 5 c.
To determine whether an increased space between ferritin
molecules in the aggregates could be used to modulate R2, we
used a 1:1.5 or 1:5 ratio of biotin actin to nonbiotin- (rho-
damine-) actin in the samples. Fig. 6 a shows TEM images of
these samples at two different magnifications. At constant
ferritin concentrations, the spacing between ferritin iron cores
in and around the aggregates increased from ;10 nm to 20–
60 nm. There were more ferritins outside of the aggregates in
the sample with a 1:5 ratio of biotin to nonbiotin actin, and
there was a heterogenous distribution of spacing and aggre-
gate sizes within the sample.
Fig. 6 b shows the values of R2 for G- and F-actin, and for
different concentrations of biotinylated actin, as obtained by
fitting the signal attenuation curves for each sample. R2 in-
creased by 23%with actin polymerization, and the difference
was significant (p , 0.05). The value of R2 also was signif-
icantly higher between the 1:1.5 samples and the 1:5 samples
of G-actin
We concluded that ferritin can be conjugated to actin in
vitro and that the ferritin-actin conjugates are observable
under electron microscopy. The polymerization of ferritin-
conjugated actin can be detected withMRI by its effect on R2,
and this effect can be modulated by changing the space be-
tween ferritins.
DISCUSSION
In this work, we studied how the aggregation of ferritin can
affect R2 in MRI measurements. Aggregation is known to
affect the relaxivities of superparamagnetic particles (26),
and here we calculated the effects of size and interparticle
spacing on the relaxivity of a model for ferritin. To the best of
FIGURE 3 TEMimages of (a) native horse spleen
ferritin and (b) aggregated ferritin, cross-linked at
short distance with DTSSP. Ferritin cages are visible
as electron-dense dots in the image. (c) The aggre-
gate diameter was estimated to be ;200 nm, corre-
sponding to 20 ferritins in the longest dimension.
Spontaneous aggregation of native ferritin was also
observed, with an average aggregate diameter
of ;75 nm.
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our knowledge, this is the first time the effects of interparticle
spacing have been examined.
We used a computational model to study the change in
relaxation rates for a number of perturber cluster sizes and
interperturber spacings in spin-echo experiments. Qualita-
tively, the change in relaxation rates with perturber cluster
size were in agreement with Weisskoff et al. (23) when the
perturbers were touching. R2 increased with cluster size, in-
dicating that relaxation was diffusion limited at these per-
turber sizes. When the space between perturbers in the
aggregates was increased, the maximum R2 also increased.
Based on the simulated results, a perturber spacing of 100–
250 nm resulted in the largest DR2. The optimal aggregate
size was ;60–100 perturbers. To control for the effect of
variations in the iron-loading factor in ferritin on the maxi-
mum DR2, we also simulated the case where the surface-field
offset was an order of magnitude greater (data not shown).
Although the maximum DR2 could be modulated in this way,
the perturber sizes and spacing to achieve maximum DR2
were approximately the same. Whereas the simulations are
for superparamagnetic clusters, they are relevant for para-
magnetic clusters and may explain the large relaxation de-
tected in nanostructures such as gadolinium-doped carbon
nanostructures (35). Our work demonstrates that it is feasible
to rationally modify the distance between ferritin in a syn-
thetic or endogenous contrast agent to modulate relaxivity,
which is consistent with previous work with dextran-coated
iron oxide particles (36).
To experimentally verify the trends predicted by the
model, ferritin was cross-linked at short distances and bound
to actin to cluster at larger distances. Cross-linking ferritin at
short spacing increased R2 by 70%, from 9 mM
1s1 to
16 mM1s1. The value of 9 mM1s1 for unaggregated
ferritin is within the range previously reported (12). Binding
FIGURE 4 (a) Short-length cross-linking of cationized
ferritin reduces MRI signal compared to uncross-linked
controls. The images were taken with a CPMG pulse
sequence with TE/TR ¼ 6/3000 ms. The samples were
embedded 1:1 in 2% agarose. (b) Effects of cross-linker
(DTSSP) concentration on apparent R2 of ferritin aggre-
gates. The increase in R2 with ferritin aggregation was
reversed by cleaving the cross-linker with DTT. (c) Ag-
gregation of ferritin increases per-iron R2 relaxivity by
70%, as measured by CPMG MRI. The DTT was added to
reverse cross-linking.
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ferritin to actin and increasing the ferritin spacing to;50 nm
increased R2 by 30%.
Because the magnetic field offset from B0 decreases as the
cube of distance from the center of a perturber, it follows that
the magnetic field 6.5 nm (2 3 r) from a ferritin molecule is
12.5% of the value at the surface. At 19.5 nm (33 r) away, the
field offset drops to 3.7%. With three-dimensionally sym-
metric aggregation, the gradient is less steep. For instance, if
the radius of the aggregation sphere is twice that of the single
ferritin, the magnetic field offset is 67% at 6.5 nm and 40% at
19.5 nm. Thus, as the aggregate size increases, (assuming a
zero-length spacer), the field perturbation is accessible to
more of the water, but the size of the perturbing field gradient
is reduced. Because the magnetic field gradient is responsible
for dephasing, the goal in improving relaxivity via aggrega-
tion is to ensure that water is exposed to the field gradient as
often as possible during the experiment. Both the effect of
aggregating at short distances and altering interparticle
spacing within aggregates can change R2. The complexity of
all of the factors involved makes it necessary to perform
simulations, as we have here, to help optimize their effects.
Inner-sphere effects are known to affect the T2 relaxivity of
ferritin (18). It is thought that water adsorbed to the surface of
the ferritin core is in rapid exchange with the bulk water,
which adds to the intrinsic T2 of ferritin in solution. However,
aggregation of ferritin is not expected to decrease exchange
of protons at the surface with the bulk water. Additionally, as
noted above, the long-range magnetic field gradient induced
at the core surface from a neighboring ferritin core, even
when aggregated, is much smaller than at the surface. The
effects of aggregation on relaxation are thus thought to come
from outer-sphere mechanisms.
An alternative explanation for the relaxivity change with
ferritin aggregation is that water becomes trapped between
ferritins inside the aggregates. Trapped water would sub-
stantially increase the phase accumulation of water in the
aggregates by forcing them to be in the vicinity of the dipolar
fields of the ferritin molecules. In the simulations, this effect
seems unlikely because, even with the largest aggregates, the
volume of the aggregate only comprises 0.3% of the total
volume of the simulated voxel. In experiments with actin-
ferritin conjugates, this effect seems unlikely in the bulk
FIGURE 5 (a and b) Fluorescence microscopy (203
magnification) of rhodamine-conjugated phalloidin in-
cubated with G-actin and F-actin, respectively. The
samples in solution were imaged on a microscope slide
using a TRITC/DiI filter (excitation 540 nm, emission 605
nm). Transmission electron micrographs of (c) ferritin-
G-actin conjugates and (d) ferritin-F-actin conjugates
adsorbed to a carbon mesh, demonstrating in vitro poly-
merization of actin-ferritin. Scale bars are 100 nm. (e)
Transmission electron micrographs of ferritin-F-actin con-
jugates embedded in 10% agar with 0.5% uranyl acetate.
Scale bar is 100 nm. (f) At higher magnification, with no
stain, individual ferritins are observed attached to the actin.
Scale bar is 20 nm.
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water, because the polymerized actin structure should pre-
vent water from becoming trapped in the middle of the fer-
ritin clusters. There is a possibility that water bound to the
surface of actin is experiencing a large dephasing magnetic
field. The case of G-actin most likely represents close-packed
ferritin in small clusters, which explains why R2 increased
rather than decreased with polymerization in these experi-
ments.
The effects of ferritin aggregation and spacing on relaxivity
depend upon the diffusion coefficient of the water, time al-
lowed during the experiment for diffusion through the gra-
dients to occur (interecho spacing), and the distance between
the perturbers in the aggregates. Additionally, the amount of
iron-loading in the ferritin determines the total signal avail-
able at a specific TE, and the distance the magnetic field
gradient extends from each molecule. In the simulations
presented here, water diffused;3mm during the experiment.
This compares to a perturber aggregate diameter range of
65 nm to 1.27 mm in the largest aggregates (53 53 5). The
peak relaxivity change occurred when this aggregate was
600 nm across. For smaller aggregates, the diameter of the
aggregate for peak relaxivity was smaller (;125 nm with the
23 23 2 perturbers). We hypothesize that this represents an
interplay between two effects: 1), Maximum relaxation for
very sparse perturbers, with diffusion distance less than the
interperturber distance, occurs when the perturber size is
largest. This is seen with the largest aggregates, where the
water experiences few perturbers but a very large gradient
when it is in the vicinity of the aggregates. 2), When per-
turbers are less sparse, the water experiences a smaller gra-
dient more often during the experiment, as happens when the
aggregates are smaller. As the diffusion coefficient increases,
there is expected to be less difference between these two ca-
ses. In general, the complicated nature of aggregation sug-
gests that it is appropriate to design a biological construct that
is tailored to the microenvironment of the cellular water and
the loading factor of ferritin.
An aim of this work was to determine optimal conditions
for aggregation of ferritin to improve R2 relaxivity for MRI. It
is instructive to consider whether these small changes in R2
by ferritin concentration and polymerization status could
potentially be detected in vivo. If one assumes some arbitrary
threshold for detection of DR2 by ferritin expression, aggre-
gation of the ferritin will thus allow detection at a lower
concentration. This threshold is still unclear. We estimate
that, given an R2 relaxivity of 10 mM
1/s, a ferritin subunit
concentration of ;200 mM (5-mM cages) is required for a
10% change in signal intensity. Based on the work presented
here, perhaps a 100-mM ferritin subunit (2.5-mM cages)
concentration could be detected if the ferritin were en-
gineered to aggregate. At this concentration, every ferritin
cage would be spaced ;70 nm apart (center-to-center) if
uniformly distributed in the entire imaging voxel, demon-
strating the high levels of ferritin expression required to be
FIGURE 6 (a) Transmission electron micrographs of
ferritin-F-actin conjugate in vitro, with two different ratios
of biotin-actin to rhodamine-actin (1:1.5 and 1:5). Three of
each sample are shown in a row. Samples were adsorbed on
a carbon grid. Ferritin is visible as punctuate dark spots
surrounding the negatively stained G- and F-actin. The
F-actin samples with a 1:5 ratio had an increased distance
between ferritin cores, with a heterogeneous distribution of
distances and cluster sizes. (b) Formation of polymerized
F-actin causes a significant (p , 0.05) increase in R2.
Relaxation times could also be modulated by the ratio of
biotinylated to unbiotinylated actin in the sample.
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detectable by MRI. However, it is known that ferritin ag-
gregation occurs to some degree in vivo in the form of he-
mosiderin (19,20), which would decrease the effect that
engineering ferritin aggregates would have.
An alternate and perhaps more interesting implication of
this work is that allowing ferritin to alter spacing in a cell can
enable reporting on the functional state of different struc-
tures. For instance, actin structure is known to change with
rapid changes in cellular ion concentrations (30–32), during
cell cycle transitions and during cell migration. Producing a
ferritin-actin form by ferritin-actin fusion, or by fusion of
ferritin to an actin-binding protein, could be used to change
spacing between ferritin and to detect actin polymerization
states that change on the order of minutes to hours. Other
cellular phenomena, such as cell signaling and apoptosis,
could potentially be detected by coupling the aggregation of
ferritin to proteins that aggregate upon activation. Previous
work has proposed controlling the aggregation of iron oxide
particles at short distances to make functional MRI contrast
agents that report on membrane potentials, enzyme activity,
or Ca21 levels (33,36–38). It is not clear yet how to effi-
ciently deliver these agents to cells, or whether the relatively
large particles would be able to diffuse through the cell on
relevant time scales. Engineering particles to change spacing
at relatively short distances (50 nm) may offer many ad-
vantages for making the aggregation of super-paramagnetic
particles a practical strategy for generating functional MRI
contrast. Actin is expressed at 1.5 mg/mL (39) in the cy-
tosol, or at a concentration of 350 mM. On average, this
would require ;3.5 3 107 actin monomers in a volume of
1 pl, corresponding to the volume of a cell of 10 mm3. This
would suggest that there are 1.5-G-actin monomers per
nanometer and that an actin-ferritin fusion must be expressed
at a concentration of 10 mM to be spaced at a distance of
50 nm if actin-ferritin is completely dispersed in the cell.
In this work, we have shown how ferritin aggregation can
change transverse MR relaxivity. A computational model
was developed to determine how the spacing and size of these
aggregates affects DR2. The model demonstrates that inter-
particle spacing within an aggregate on the order of 100 nm
modulates R2. We chemically cross-linked ferritin cages in
vitro at short distance, and found that relaxivity was increased
by 70% with ferritin aggregates of 100 mm isotropically. We
also conjugated ferritin to actin, which was then polymerized
to increase R2 relaxivity by 30%. We hypothesize that the
controlled in vivo aggregation of ferritin can be achieved to
improve the detectability of gene expression in mammalian
cells and binding ferritin to cellular micro-structures, such as
the actin cytoskeleton, may be a way to generate MRI con-
trast from changes in cell function.
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